Carvedilol
Product Images NDC 10135-637
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 10135-637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol 02)
Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol 03)
Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol 04)
Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol 05)
Principal Display Panelndc 10135-0633-01carvedilol Tablets Usp3.125 mg100 Tabletsrx Only (Carvedilol 06)
Principal Display Panelndc 10135-0634-01carvedilol Tablets Usp6.25 mg100 Tabletsrx Only (Carvedilol 07)
Principal Display Panelndc 10135-0635-01carvedilol Tablets Usp12.5 mg100 Tabletsrx Only (Carvedilol 08)
Principal Display Panelndc 10135-0637-01carvedilol Tablets Usp25 mg100 Tabletsrx Only (Carvedilol 09)
Carvedilol 0a
Carvedilol 0b
Carvedilol 0c
Carvedilol 0d
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.